V. Papadimitrakopoulou

Phenotype and Genotype of Advanced Premalignant Head and Neck Lesions After Chemopreventive Therapy

Li Mao, V. Papadimitrakopoulou, Dong M. Shin et al. · JNCI Journal of the National Cancer Institute · 1998 · 167 citations · Full text

Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: Preliminary results

R. Komaki, Lee J.S., B. Kaplan et al. · Seminars in Radiation Oncology · 2002 · 95 citations

Medicine, Metronomic Therapy, Preliminary Results +8

OA02.06 A Phase II Trial of Poziotinib in EGFR and HER2 exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC)

John V. Heymach, Marcelo V. Negrão, Jacqulyne Robichaux et al. · Journal of Thoracic Oncology · 2018 · 86 citations · Full text

Medicine, Pathology, Cancer Treatment +7

Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma

Erminia Massarelli, Heather Lin, Lawrence E. Ginsberg et al. · Annals of Oncology · 2015 · 85 citations · Full text

Phase Ii Trial, Medicine, Head And Neck Cancer +5

The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis

V. Papadimitrakopoulou, Eleanor Brown, Dandan Liu et al. · Cancer Letters · 2005 · 40 citations

Prognostic Role, Medicine, Pathology +8